Philip Morris (PM) Stock Forecast & Price Target

Philip Morris Intl is fundamentally attractive because its smoke-free portfolio is compounding quickly, with IQOS, ZYN, and VEEV supporting strong mix and a structurally better earnings profile than a business still anchored by combustibles. Recent results reinforced that thesis, with HSD organic revenue growth of 7.6%, reported revenue growth of 10.4%, and 13.6% LC EPS growth, while triple-digit gross margin expansion and nearly 11% organic operating profit growth showed both pricing power and operating leverage. Management’s decision to keep full-year EPS guidance unchanged while reinvesting excess earnings into ZYN and future launches signals confidence in durable cash generation, disciplined capital allocation, and a widening runway for smoke-free growth.

Philip Morris Intl is facing a bearish fundamental setup because its growth increasingly depends on IQOS and U.S. nicotine pouches just as management sees IQOS becoming a market-share donor and competition in pouches intensifying. At the same time, combustible volumes are expected to decline faster than pricing can offset, which would pressure revenue, gross margin, and earnings, while regulatory uncertainty around the IQOS PMTA in the U.S. adds operational risk. Although third quarter estimates still call for 4% organic revenue growth, 30bps of gross margin expansion, and 3% EPS growth, these figures appear vulnerable to weak consumer demand, FX headwinds, and compliance hurdles.